Pharmaceutical manufacturers of Ivermectin

Founded in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise featuring whole chain, multi-regional integration of research, production and marketing as well as development of drug substances and preparations. In 2000, an A-share was issued in order to enter the stock market as a state-owned listed company. As of 2021, Hisun Pharmaceutical is now one of the largest producers of antibiotics and anti-tumor drugs in China and has been listed in the Top 500 Chinese manufacturing enterprises and the Top 100 Chinese pharmaceutical enterprises multiple times. In 2020 Hisun Pharmaceuticals received special recognition from the Joint Prevention and Control Team from the State Council of the People’s Republic of China for their extraordinary efforts in the fight against the epidemic, and Hisun Pharmaceutical was awarded with the “Anti COVID-19 Advanced Collective in Ministry of Industry and Information Technology".

Established in 1958, Qilu Pharmaceutical is now one of the leading vertically integrated pharmaceutical companies in China that develops, manufactures and distributes both Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Qilu currently has 12 subsidiaries, 11 domestic manufacturing sites and over 3,9000 employees worldwide. Qilu ranks among Top 5 in Chinese pharmaceutical industry in 2022. Dedicated to offering high-quality & trustworthy medicines to the world and improving people‘s well-being, Qilu is vigorously exporting its products to over 100 countries and regions around the world.

Delta Synthetic was founded in 1961. The mission of Delta is production of highest quality active pharmaceutical ingredients. Delta Synthetic Co., Ltd. has filed Drug Master Files (eCTD format) for its facility and major products. The production facility is inspected regularly by US FDA and TFDA (PIC/S member). Final dosage forms made with Delta's bulk products are widely distributed in the United States, Europe, Asia and Oceania.

Our objective is to pave the path to a more wholesome future. However, we are also concerned about the manner in which we collectively achieve this goal. Being a company whose products impact the well-being of individuals worldwide, we uphold ourselves to a stringent standard and anticipate others to treat us likewise. We are advocates of transparent, truthful, and principled operation with the utmost level of ethics and honesty. This encompasses ensuring the company's compliance with all relevant laws and regulations on a global scale.

NCPC International Corp. is a platform for international trade of NCPC and the exclusive channel for exporting the preparations of NCPC, the business scope covers import and export trade, CMO, technology transfer and pharmaceutical logistics in domestic. NCPC International Corp. provides all-around and one-stop sales and service on APIs, preparations, medical equipments and consumables, based on creating more values for foreign customers. NCPC International Corp. has been exporting to more than 80 countries and regions, increasing the overseas sales yearly, ranking 1st on exporting preparations in china mainland for last continuous 3 years. NCPC International Corp. is a worldwide supplier of generic pharmaceuticals. As an Anti-infective expert and your local one- stop partner NCPC International Corp. will provide you the most comprehensive products and the most professional and efficient services. We are sincerely expecting to cooperate with friends from all sectors for shared development and a brighter future!

Hovione brings over six decades of experience as a CDMO and serves as a specialized integrated provider delivering solutions for drug substance, drug product intermediate, and drug product. With four FDA examined facilities in the United States, China, Ireland, and Portugal, as well as research laboratories in Portugal and the United States, the company supplies pharmaceutical customers with services for the development and compliant production of innovative drugs, including highly potent compounds. Hovione delivers a comprehensive range of development services and manufacturing capabilities in particle engineering such as Spray Drying.

Apeloa Pharmaceutical Co., Ltd. is a major high-tech enterprise at the state level and a significant player in the pharmaceutical industry in Zhejiang Province. Our company focuses on the exploration, production, and marketing of pharmaceutical goods, primarily specializing in crude drug (API), contract R & D, production service (CDMO), and preparation (FDF) operations. Our product range is predominantly focused on cardio-cerebrovascular, anti-infection, anti-tumor, and other medical treatment areas. Currently, we produce over 70 types of raw materials on a large scale, with 11 of them exceeding 100 million in sales.

We are the primary manufacturer of Avermectin worldwide and the leading producer of Ivermectin in Asia, with an annual production that constitutes half of the total in China. Additionally, we hold the top position as the producer for Tiamulin, Eprinomectin, and Emamectin Benzoate in China.

The Saraf group of enterprises was established by the forward-thinking Shri Mahavir G. Saraf in 1952. Sarex Overseas represents a segment of the Saraf group of corporations, and its primary operations center on being a prominent producer of Fine Chemicals and API Intermediates within India. The corporate headquarters of Sarex Overseas is situated in Mumbai, while its manufacturing facility is located in MIDC, Tarapur, which is approximately 100 kilometers from Mumbai in India. Sarex, which was founded in 2002, has garnered a reputation as a reputable Exporter, Manufacturer, and Supplier in India, focusing on producing Active Pharmaceutical Ingredients (API), Bulk Drug Intermediates, and Veterinary Medicines, including IVERMECTIN EP, among others. The organization's adept team of professionals, under expert guidance, processes all products, and the finished range undergoes thorough scrutiny by quality analysts based on various parameters such as composition, pH value, viscosity, and packaging. The company utilizes top-notch materials for packaging. Sarex specializes in the production of high-quality organic fine chemicals for the pharmaceutical and electronics industries, with a focus on Fridel craft, halogenation, nitration, oxidation, and high-pressure reactions. Notably, Sarex excels in process development and customer synthesis, operates pilot plants, and engages in bulk production of heterocycles like Tetrazoles, Triazines, and Quinazolines, among others. Its multipurpose plants include Glass-lined reactors, Stainless steel reactors, high-pressure reactors, and high vacuum distillation units, all supported by QA, QC, and R&D. The company serves as a supplier to numerous catalogue companies for small and bulk quantities and also provides toll manufacturing for large multinational companies.